Abstract:55 Pancreatic transplantation is an important therapeutic alternative for type I diabetic patients with renal failure. Since systemic immunosuppression is required to prevent acute rejection and maintain long-term graft function, the enthusiasm for pancreas transplantation to restore normoglycemia and prevent the complications in non-uremic diabetic patients is muted. Inhibition of the CD28/B7 pathway during T cell activation by CTLA4Ig produces a state of T cell anergy, resulting in prolonged graft survival and donor-specific tolerance. We hypothesized that local production of CTLA4Ig from the pancreas graft, achieved by adenoviral-mediated transfer of the CTLA4Ig gene to the graft ex vivo, may inhibit the immune responses against the pancreas and promote long-term graft survival. Methods: Pancreaticoduodenal grafts from Lewis donors were infected by AdlacZ or AdCTLA4Ig via arterial perfusion of 2.5×1010 virus, followed by 1.5-hour ex vivo incubation at 4°C. Grafts were washed with saline and transplanted into STZ-diabetic recipients (Lewis or W/F). Syngeneic AdlacZ-infected grafts were harvested at various time points after transplantation and LacZ expression was examined by X-gal staining. All animals with graft rejection were sacrificed at the time of rejection, and graft morphology examined histologically. To determine the local vs. the systemic effect of the locally delivered CTLA4Ig, co-transplantation of the transfected pancreas with non-transfected heart allografts were performed in two allogeneic strain combinations. Results: X-gal staining of pancreas isografts demonstrated lacZ gene expression in the endocrine and exocrine cells of the donor grafts beginning 1 day post-transplantation, reaching peak levels by day 3. LacZ expression was also observed in the recipient liver, however, by day 7 lacZ expression diminished in the liver, and virtually disappeared by day 14, though high levels of LacZ in the pancreas grafts were detected. AdCTLA4Ig toxicity was evaluated by syngeneic transplantation of virus-infected pancreases (n=4) and a survival time of greater than 100 days was achieved. Transplantation of control (non-treated, n=6) or AdlacZ-infected Lewis rat pancreases (n=4) into W/F recipients gave a mean survival time of 17 and 17.5 days, respectively. However, transplantation of AdCTLA4Ig-infected pancreas grafts (n=6) resulted in permanent survival of the graft (> 100 days). Subsequent transplantation of donor strain hearts (n=3) did not induce rejection, and long-term heart allograft survival was observed. Transplantation of third party (ACI) heart allografts (n=3) were rejected, though the survival time of the grafts was prolonged to a small degree vs. control (MST 22d vs. 7d, p<0.01). In the co-transplantation model, the non-transfected hearts (H) were rejected while the transfected pancreases (Pd) were accepted, confirming the effect of locally delivered CTLA4Ig. TableTableConclusion: This study demonstrates that arterial perfusion of the pancreas with adenovirus can lead to successful viral infection and gene transfer. Local expression of the CTLA4Ig gene can produce long-term graft survival and donor-specific tolerance in the rat pancreas transplant model. The immunosuppressive effect of CTLA4Ig protein appears limited to the transfected tissue rather than a systemic phenomenon.

Induction of Immunotolerance in Mouse Pancreatic Islet Transplantation Through PD-1/PD-L1 Costimulatory Pathway

PD-1/PD-L1 costimulatory pathway-induced mouse islet transplantation immune tolerance.

Blockade of the OX40/OX40L Pathway and Induction of PD-L1 Synergistically Protects Mouse Islet Allografts from Rejection.

An Efficient Combination Immunotherapy for Antitumor Immunity Without Accelerating Cardiac Allograft Rejection.

Ex Vivo Anchored PD‐L1 Functionally Prevent in Vivo Renal Allograft Rejection

LOCAL EXPRESSION OF RECOMBINANT CTLA4IG GENE IN THE PANCREAS INDUCES PERMANENT PANCREAS GRAFT SURVIVAL AND DONOR-SPECIFIC TOLERANCE:

Effect of Porcine Islet Loading Adv-porcine CTLA4-Ig Blocking the Direct Recognition Pathway in Xenotransplantation

Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide Gad(500-585)

Simultaneous blockade of the CD40/CD40L and NF-κB pathways prolonged islet allograft survival.

Tolerance induction to islet allografts

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Porcine CTLA4-Ig prolong islet xenografts in rats by downregulating the direct pathway of T-cell activation.

Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation model.

A Novel Immunodeficient Hyperglycemic Mouse Carrying the Ins1 Akita Mutation for Xenogeneic Islet Cell Transplantation

Enhancing human islet xenotransplant survival and function in diabetic immunocompetent mice through LRH-1/NR5A2 pharmacological activation

[Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].

Hemo Oxygenase-1 Induction in Vitro and in Vivo Can Yield Pancreas Islet Xenograft Survival and Improve Islet Function

Up-Regulation of Donor Dendritic Cell PD-L1 Expression Reduced Recipient Lymphocyte Activation and Proliferation in Vitro.

Transplantation of rat islets transduced with human heme oxygenase-1 gene using adenovirus vector.

Transplantation of Encapsulated Adult Pig Islets in Peritoneal Cavity of Diabetic Mice

201.1: Co-engineering Pancreatic Islets with Novel Forms of Thrombomodulin and CD47 As an Effective Means of Mitigating Instant Blood-Mediated Inflammatory Reaction